BIOSGN — Biosergen AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Biosergen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	PRESS	ARS	ARS
Standards:	SAS	SAS	—	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.589	21.7	29.3	1.88	50.6
Net Total Accounts Receivable
Net Total Receivables	1.22	3.17	4.64	0.342	0.492
Prepaid Expenses
Total Current Assets	4.8	29.5	34	7.2	53
Total Assets	4.8	29.5	34	7.2	53
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15.7	9.25	11.2	5.08	4.81
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.7	9.25	11.2	5.08	4.81
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-10.9	20.2	22.8	2.12	48.2
Total Liabilities & Shareholders' Equity	4.8	29.5	34	7.2	53
Total Common Shares Outstanding